XNAS: SABS
SAB Biotherapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
SAB Biotherapeutics Inc is a clinical-stage biopharmaceutical company focused on developing multi-specific, high-potency, human immunoglobulin G (hIgG) to treat and prevent immune and autoimmune disorders. The company's lead product candidate, SAB-14...
Read More
2.98
0.09
(3.11%)
659.6K
XNAS Volume
XNAS 09 Oct, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
SAB Biotherapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..